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Isolation of  
Rickettsia typhi 
from Human,  
Mexico
To the Editor: Murine typhus is 
a febrile illness caused by Rickettsia 
typhi. The clinical manifestations are 
nonspecific, and the signs and symp-
toms resemble those of several other 
febrile illnesses. Murine typhus can 
be a self-limiting infection; however, 
it should be diagnosed and treated be-
cause complications and even death 
can result (1). In Mexico, particularly 
in Yucatan State, cases of murine ty-
phus in humans and high prevalence 
of antibodies in healthy blood donors 
have been reported (2,3). In 2012, we 
isolated R. typhi from a human patient 
in southeastern Mexico by using a 
simple and effective method, an adap-
tation of the centrifugation shell vial 
method to cell culture plates.
The patient, a 23-year-old 
man from Dzibzantun (21°15′00″N, 
89°03′00″W), in the northeastern part 
of Yucatan State, was referred for pos-
sible diagnosis of rickettsial infection. 
He had a low-grade fever (37.6°C) 
and a maculopapular rash on the tho-
rax and upper and lower extremities. 
The patient reported having cats in 
the house, but no fleas or ticks were 
observed. Clinical laboratory findings 
were within reference ranges. Test re-
sults were negative for dengue virus, 
but the Weil-Felix (Proteus OX19) test 
result was positive (titer 1:164). Single-
step PCR amplification was performed 
by using genus-specific primers for 
the 17-kDa lipoprotein and the citrate 
synthase gene (gltA), as described pre-
viously, to obtain amplicons of 434 bp 
and 380–385 bp (4). PCR was positive 
for R. typhi, and 100 mg of oral doxy-
cycline 2 times per day for 7 days was 
prescribed; the rash cleared.
We subjected 5 mL of blood to 
centrifugation for 1 hour at 1,000 
rpm and then stored the plasma at 
–80°C. Blood samples from other pa-
tients were used as controls. A total 
of 50,000 Vero cells were grown in 8 
central wells of a 24-well cell culture 
cluster (Corning Incorporated, Corn-
ing, NY, USA) with minimal essential 
medium (MEM; Biowest, Nuaillé, 
France) supplemented with 10% fe-
tal bovine serum (Biowest) and in-
cubated at 37°C with 5% CO2 for 48 
hours to obtain 95% confluence. We 
then thawed 700 mL of the plasma 
in a 37°C water bath. The MEM was 
discarded, and the wells were refilled 
with 250 mL each of a mixture of the 
plasma and fresh medium at a 1:3 
ratio. The plaque was covered with 
parafilm and centrifuged at 700 g for 
60 minutes at 22°C. The supernatant 
was discarded and replaced with 1 mL 
of MEM supplemented with 5% fetal 
bovine serum, 100 U penicillin, 100 
µg streptomycin, and 250 ng ampho-
tericin B (Sigma Aldrich, St. Louis, 
MO, USA) and incubated at 33°C 
with 5% CO2.
On day 3 after sample inoculation, 
the antimicrobial drug–containing me-
dium was removed and replaced with 
MEM without antimicrobial drug 
and supplemented with 5% fetal calf 
serum (HyClone Laboratories, Inc., 
South Logan, UT, USA). Medium was 
changed every 3 days until day 15. A 
cell sample from each well was tested 
for infection at days 9 and 15 by using 
Gimenez stain and PCR with 17 kDa 
and gltA primers.
Gimenez staining on day 15 
yielded numerous red-stained bacteria 
in the cytoplasm of Vero cells in the 
8 wells used. A single scraping of the 
cells from the positive wells was in-
oculated onto confluent layers of Vero 
cells, which enabled establishment of 
the isolate.
Three PCR amplicons of the 
17kDa- and gltA-specific primers 
(4–6) from positive wells were fully 
sequenced. After removing primer 
sequences, we compared amplicon 
sequences by conducting a gapped 
BLAST 2.0 (http://blast.st-va.ncbi.
nlm.nih.gov/Blast.cgi) search of the 
GenBank database; the 17-kDa (ac-
cession no. JX198507) and gltA (ac-
cession no. KC469611) gene fragment 
sequences showed 100% identity with 
R. typhi strain Wilmington (accession 
no. AE017197.1).
Murine typhus has been reemerg-
ing in southeastern Mexico for the past 
6 years (3,7). Active epidemiologic 
surveillance led to early detection of 
human cases and opportune treatment, 
thereby decreasing the rate of severe 
illness. However, the prevalent social 
and cultural conditions in small villag-
es, with close contact with domestic, 
peridomestic, and wild animals, facili-
tate the transmission of this fleaborne 
rickettsiosis; human infections, such 
as the case presented here, still occur.
We replaced shell vials with cell 
culture plates and isolated rickett-
siae from a biological sample from 
a patient with acute murine typhus. 
The method is as simple as the shell 
vial centrifugation technique and is 
highly sensitive and easy to perform, 
making it an excellent choice for 
rickettsiae isolation when shell vials 
are not available.
In the United States, isolation of 
R. typhi from a human was last report-
ed >50 years ago (8). The case reported 
here reinforces the need to extend sur-
veillance to small towns and villages 
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in Yucatan State. It also shows that a 
shell vial alternative method for R. ty-
phi isolation is simple and effective.
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Zika Virus Infection 
after Travel  
to Tahiti,  
December 2013
To the Editor: Zika virus 
(ZIKV), a member of the family Fla-
viviridae, is a mosquito-borne virus 
that is endemic to Africa and South-
east Asia. ZIKV causes illness that is 
similar to dengue fever, characterized 
by joint pain, myalgia, headache, and 
rash (1). ZIKV has caused several 
recent outbreaks, including one in 
Micronesia in 2007 (2) and one in 
French Polynesia (≈30,000 cases) 
ongoing since October 2013 (3) and 
spreading to New Caledonia and Eas-
ter Island (4). We report the clinical 
and laboratory findings for a patient 
with ZIKV infection imported from 
Tahiti, French Polynesia.
The previously healthy 31-year-
old woman from Norway was admit-
ted to the Oslo University Hospital, 
Norway, on December 13, 2013. Six 
days earlier, she had returned from a 
14-day vacation to Tahiti, where she 
mainly stayed in the capital, Pape’ete, 
and took a short trip to the island of 
Mo’orea. One day after her return to 
Norway, she experienced fever, in-
tense joint pain, and myalgia. Sub-
sequently, a maculopapular rash de-
veloped. At the time of admission, 
her temperature was 37.7°C, and she 
had enlarged nuchal lymph nodes; 
injected conjunctivae; and a macu-
lopapular rash on her trunk, extremi-
ties, and face (online Technical Ap-
pendix, http://wwwnc.cdc.gov/EID/
article/20/8/14-0302-Techapp1.pdf). 
Clinical examination findings were 
otherwise unremarkable. Laboratory 
tests showed leukopenia of 2.7 × 109 
cells/L (reference range 3.5–10 × 
109/L), with mild lymphopenia of 1.0 
× 109 cells/L (reference range 1.5.–4.0 
× 109/L) and neutropenia of 1.4 ×109 
cells/L (reference range 1.5–7.3 × 
109/L). No thrombocytopenia or el-
evated liver enzyme levels were de-
tected. C-reactive protein levels (1.4 
mg/L) were within reference range.
Because of the patient’s clinical 
picture and travel history, an acute 
ZIKV infection was suspected and 
several diagnostic tests were ordered. 
In a serum sample taken 5 days after 
symptom onset, no IgM or IgG against 
ZIKV, dengue virus (DENV), Japa-
nese encephalitis virus, yellow fever 
virus, or chikungunya virus was de-
tected by in-house indirect immuno-
fluorescence (5,6). Only a weak IgG 
titer of 1:20 (and no IgM) against tick-
borne encephalitis virus was found 
(cutoff <1:20). Test results for DENV 
nonstructural protein 1 antigen (Plate-
lia; Bio-Rad, Hercules, CA, USA) and 
generic flavivirus reverse transcrip-
tion PCR (RT-PCR) (6) were nega-
tive. Thus, for increased sensitivity, 
quantitative ZIKV-specific real-time 
RT-PCR (6) with the AgPath-ID One-
Step RT-PCR Kit (Life Technologies, 
Carlsbad, CA, USA) was performed 
according to the manufacturer’s in-
structions, and results were positive. 
ZIKV RNA load was 1.6 × 105 copies/
mL; in vitro–transcribed RNA from a 
1412	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	20,	No.	8,	August	2014
